ArticleActa Cardiologica Sinica2024

Risks and Benefits of Continuing Renin-Angiotensin-Aldosterone System Inhibitors in Critically-Ill Patients.

Ruey-Hsing Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.